Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients - Trial NCT06346210
Access comprehensive clinical trial information for NCT06346210 through Pure Global AI's free database. This phase not specified trial is sponsored by Uppsala University and is currently Completed. The study focuses on COVID-19. Target enrollment is 4000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Uppsala University
Timeline & Enrollment
N/A
Apr 02, 2024
Apr 02, 2024
Primary Outcome
Ventilator free days alive
Summary
Tracheostomy is a medical procedure performed on the front of a persons neck. It is used to
 create a connection between the persons trachea and a mechanical ventilator instead of using
 a tube going through the mouth into the trachea, oral intubation. Living with a tracheostomy
 tube is less stressful compared to oral intubation and facilitate being awake and the start
 of training on spontaneous ventilation in mechanically ventilated patients. Studies of the
 timing of tracheostomy are either severely affected by methodological bias of to small to
 determine an effect. Thus, it is not known what the optimal timing of the tracheostomy is in
 mechanically ventilated COVID-19 patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06346210
Non-Device Trial